Xenon Pharmaceuticals (XENE) EBITDA Margin Growth (1y) (2014 - 2022)
Xenon Pharmaceuticals (XENE) EBITDA Margin Growth (1y) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.87 Mn |
| Jun 30, 2022 | -464,145.00 |
| Mar 31, 2022 | 17,035.00 |
| Dec 31, 2021 | -41,372.00 |
| Sep 30, 2021 | -4,401.00 |
| Jun 30, 2021 | -100,951.00 |
| Mar 31, 2021 | -25,500.00 |
| Dec 31, 2020 | 9,746.00 |
| Sep 30, 2020 | 10,776.00 |
| Dec 31, 2017 | -4.89 Mn |
| Sep 30, 2017 | -149,918.00 |
| Jun 30, 2017 | -5.11 Mn |
| Mar 31, 2017 | -4.90 Mn |
| Dec 31, 2016 | -137,200.00 |
| Sep 30, 2016 | -175,596.00 |
| Jun 30, 2016 | -154,632.00 |
| Mar 31, 2016 | -78,839.00 |
| Dec 31, 2015 | -8,138.00 |
| Sep 30, 2015 | -8,474.00 |
| Jun 30, 2015 | -2,109.00 |